Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Cargurus Carg Stock Maintain Expansion Price At 33.33 Down 0.66 20260402 Nqp Tests Support Bearish Momentum Builds 20260403 1 Is Estee El Stock A Buy Or Sell Price At 70.91 Up 2.59 20260406 Is Reinsurance Rzb Stock Testing Support Price At 25.07 Up 0.18 20260406 Is Bioaffinity Biaf Stock Showing Strength Price At 3.88 Down 1.02 20260406 The moat HNI Corporation HNI is building for long term dominance Ticks Down 20260508 Is Crown Crafts CRWS stock worth watching today Modest Uptick 20260418 Is A10 Networks ATEN stock in a strong position Q4 2025 Better Than Expected 17 YQ Stock Strategic Buy 815 20260418 REE REE Stock Detailed Breakdown On the Radar 20260420 CarGurus CARG Stock Movement Analysis Bullish Sentiment 20260422 OGN Organon reports 15 earnings miss but stock holds steady as investors eye cost cuts and pipeline progress WST West delivers Q4 2025 doubledigit EPS beat shares edge higher on 62 percent yearoveryear revenue growth The Walt Disney Company DIS Former CEO Bob Iger Appointed Advisor to Thrive Capitals New Permanent Capital Vehicle Targeting Irreplicable Hard Assets What Adv Energy AEIS doing to improve profitability Q1 2026 Better Than Expected Generative AI Industry Legal Regulatory Risk Update BRRWW ProCap CEO signals cautious longterm growth outlook while discussing latest quarterly earnings results Public Service Enterprise Group PEG Declares 067 Quarterly Dividend Lifts LongTerm Growth Outlook Amid Nuclear Energy Tailwinds Netflix Inc NFLX Bullish MonetizationDriven Thesis Supports Compelling LongTerm Entry Point Meta Stock Slips as Internet Disruptions in Iran Weigh on User Growth AI Shock Indian IT Valuations Plunge to Subprime Crisis Levels AvePoint AVPT Q1 2026 Earnings 010 EPS Surges Past 008 Estimates Palantir Technologies PLTR Crushes Q1 2026 Estimates EPS 033 Tops Views Dollar Edges Up as Iran Peace Hopes and Fed Rate Outlook Drive Cautious Trading Why BioLineRx BLRX Just Dropped 621 What to Watch 20260518 Traws Pharma TRAW Stock Today Rallies 087 Resistance at 183 20260514 HBT Financial HBT Slips 133 Testing 2575 Support 20260517 Gildan Activewear GIL Climbs 175 Testing Key Resistance Near 61 Affil Mgmt AMG Q1 2026 Beat Revenue NA EPS Exceeds by Significant Estrella Immunopharma ESLA Q1 2026 Earnings Slump EPS Falls Short of 018 Target Intellicheck Reports Profit Swing on Record SaaS Revenue in Q1 International Aid Sector Faces Pressure to Overhaul Outdated Models Amid Budget Cuts SpaceX Scrubs Starship V3 Test Flight Reschedules for Friday IPO Filing Reveals 15 Billion Program Cost Trump Mobile Investigates Potential Data Exposure Affecting Thousands of Prospective Customers CBS and Paramount Drop Copyright Claims Over Stephen Colberts Viral Parody Appearance CRISPR Therapeutics Releases First Quarter 2026 Results Key Updates on Gene Editing Pipeline UBCP Q4 2022 Earnings Solid EPS Performance Drives Positive Stock Movement Teleflex Q1 2026 Earnings EPS Beats Estimates by 14 as Company Maintains Steady Performance Loews Corporation Q1 2026 Earnings EPS of 163 Driven by Diversified Portfolio Grand Canyon Education Inc LOPE Q1 2026 Earnings EPS Surpasses Estimates Amidst Steady Operations EDN Q4 2024 Earnings Massive EPS Surprise Masks Broader Concerns as Stock Declines Anixa Biosciences ANIX Edges Higher on AboveAverage Volume Testing Key Resistance Kearny Financial Corp KRNY Hovers Near Support as Trading Remains Subdued EPAM Systems Retreats Key Support Levels Under Scrutiny Amid 292 Decline SPSC Commerce Inc SPSC Moves Higher as Support Holds Firm CelSci CVM shares surge 10 after Q4 earnings beat quarterly loss narrower than analysts expected What First FXNC is doing that smart money tracks Investors Pile In 20260508 NCPL Netcapital falls 38 today as wider than expected Q1 2026 loss sparks negative investor sentiment How Voyager Technologies VOYG performance reflects its true potential Institutional Demand 20260506 RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss